Globe Life (GL) FY2025 results: revenue $6.0 billion, up 3.7% on the year
Globe Life Inc. (GL) reported revenue of $6.0 billion for fiscal 2025, the year ended 31 December 2025, up 3.7% on the year before. Net income was $1.2 billion, up 8.4%, and diluted earnings per share $14.07. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 1 raised.
- Quarter net income per share rose: Fourth quarter net income was $3.29 per diluted share, against $3.01 a year earlier. Net income is the GAAP measure reported alongside net operating income.
- Quarter operating income per share up 8%: Net operating income was $3.39 per diluted share, against $3.14 a year earlier, up 8%. In dollars, quarterly net operating income was $273,735 thousand, up 3%.
- American Income life sales rose 10%: American Income life net sales rose 10% and life premium rose 6%. Its life underwriting margin rose 5% to $208,263 thousand.
- Life and health net sales both grew: Life net sales rose 11% in the quarter and health net sales rose 71%. Net sales are annualized premium issued, net of cancellations in the first thirty days after issue.
- United American health sales jumped: United American health net sales rose from $30 million to about $77 million. Health premium at that division rose 14% to $173,197 thousand.
From this 10-K
Globe Life is an insurance holding company that sells individual life insurance and supplemental health insurance to lower middle-income and middle-income households in the United States. The products are individual policies, and the company describes the lower middle-income to middle-income market it serves as underserved. It was incorporated in Delaware in 1979 and says it has served the same market with essentially the same products for over 60 years.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 5,994 | 5,778 | 5,448 | +3.7% | |
| Gross profit | n/a | n/a | 1,260 | ||
| Gross margin | n/a | n/a | 23.1% | ||
| Operating income | 1,436 | 1,327 | 1,265 | +8.2% | |
| Operating margin | 24.0% | 23.0% | 23.2% | ||
| Interest expense | 141 | 127 | 102 | +11.1% | |
| Pre-tax income | 1,436 | 1,327 | 1,194 | +8.2% | |
| Income tax | 275 | 256 | 224 | +7.4% | |
| Effective tax rate | 19.1% | 19.3% | 18.7% | ||
| Net income | 1,161 | 1,071 | 971 | +8.4% | |
| Net margin | 19.4% | 18.5% | 17.8% | ||
| Diluted EPS | $14.07 | $11.94 | $10.07 | +17.8% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 1,396 | 1,402 | 1,482 | -0.4% | |
| Capital expenditure | 142 | 71.0 | 49.6 | +100.6% | |
| Free cash flow | 1,254 | 1,331 | 1,433 | -5.8% | |
| Free cash flow margin | 20.9% | 23.0% | 26.3% | ||
| Cash from investing | -644 | -642 | -926 | ||
| Cash from financing | -768 | -716 | -541 | ||
| Depreciation | 30.0 | 27.0 | 21.0 | +11.1% | |
| Share-based compensation | 53.4 | 40.1 | 30.7 | +33.0% | |
| Buybacks | 881 | 1,002 | 511 | -12.1% | |
| Dividends paid | 86.1 | 85.5 | 84.1 | +0.7% | |
| Dividend per share | $1.08 | $0.96 | $0.90 | +12.5% | |
| Diluted shares, weighted | 83m | 90m | 96m | -8.0% | |
| Shares outstanding at period end | 92m | 97m | 102m | -5.1% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 5,975 | 5,306 | 4,487 | +12.6% | |
| Debt | 2,625 | 2,740 | 2,116 | -4.2% | |
| Other liabilities | 22,214 | 21,031 | 21,449 | +5.6% | |
| Total liabilities and equity | 30,814 | 29,076 | 28,051 | +6.0% | |
| Fixed assets | 370 | 284 | 240 | +30.0% | |
| Goodwill | 490 | 490 | 482 | 0.0% | |
| Investments | 315 | 85.0 | 81.7 | +270.1% | |
| Cash and equivalents | 145 | 165 | 103 | -12.5% | |
| Other assets | 29,494 | 28,051 | 27,145 | +5.1% | |
| Total assets | 30,814 | 29,076 | 28,051 | +6.0% |
10-K for the year ended 31 December 2025, filed 25 February 2026: the filing.